Bayer’s colorectal cancer drug increases survival
January 19, 2012Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib
Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …
Lucentis approved in China
January 18, 2012Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets
Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …
Lundbeck gets award for manufacturing excellence
January 18, 2012Manufacturing and Production Lundbeck, Shingo, manufacturing
Efforts by Lundbeck to boost the productivity of its manufacturing operations have borne fruit, with the company cutting costs by …
Former Bristol-Myers Squibb man becomes head of Savient Europe
January 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Savient
Savient Pharmaceuticals has appointed David Veitch as the new president of its European division. Veitch joins the specialist biopharma firm …
Pfizer pulls plug on Alzheimer’s drug
January 18, 2012Research and Development, Sales and Marketing Medivation, Pfizer, dimebon
Pfizer and Medivation have written off their Alzheimer’s candidate dimebon after another Phase III failure. The firms said a 12-month …
Countdown to PM Society Advertising Awards begins
January 18, 2012Medical Communications, Sales and Marketing PM Society Advertising Awards, pm society
The Pharmaceutical Marketing Society’s Advertising Awards, one of the most significant dates in the UK pharma industry calendar, are approaching …
Novartis reverses plant closure decision
January 18, 2012Manufacturing and Production, Research and Development, Sales and Marketing Basel, Diovan, Novartis, Nyon, closure, job cuts
Novartis has said it will not close down a plant in Switzerland that had been due for closure, and has …
BMJ blasts Roche for withholding Tamiflu data
January 18, 2012Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO
Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …
The work of NICE International
January 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kalipso Chalkidou, NICE
NICE, or the National Institute for Health and Clinical Excellence, to give it its full title, is world famous for …
CoreLab Partners opens office in Tokyo, Japan
January 17, 2012Research and Development
Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …
Avastin now available in UK for ovarian cancer
January 17, 2012Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Roche, avastin
Roche’s Avastin is now available as a treatment for women with ovarian cancer in the UK. Avastin (bevacizumab) can now …
Government spends £100 million on winter care
January 17, 2012Sales and Marketing CCG, PCTs, government, health bill
The government is to give doctors in Clinical Commissioning Groups (CCGs) an extra £100 million to spend on improving patient …
Oxford BioTherapeutics appoints C. Glenn Begley as a senior clinical advisor
January 17, 2012Business Services, Research and Development, Sales and Marketing C. Glenn Begley, Oxford Biotherapeutics
Oxford BioTherapeutics has appointed C. Glenn Begley as a senior clinical advisor and non-executive director of the firm. Dr Begley, …
Lundbeck launches bipolar drug Sycrest in the UK
January 17, 2012Sales and Marketing Lundbeck, Saphris, Sycrest, zyprexa
Lundbeck has launched Sycrest in the UK for the treatment of acute attacks of bipolar I disorder. Sycrest (asenapine) is …
Pharma manufacturing news in brief
January 17, 2012Manufacturing and Production Biovest International, Corealis, OctoPlus and Tris Pharma, Toray
Toray buys a stake in MicroBiopharm Japan, Corealis wins a manufacturing contract from Kedem Pharma, plus updates from Biovest International, …
Contract research news in brief
January 17, 2012Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma
A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …
Otsuka and UCB scale down collaboration
January 16, 2012Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB
Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …
AstraZeneca looks for new partners to bolster pipeline
January 16, 2012Business Services, Research and Development, Sales and Marketing AstraZeneca, BMS
AstraZeneca has used a recent healthcare conference in San Francisco to call for new drug development partners. Speaking at the …
NantWorks to invest $85.5m in former Pfizer plant
January 16, 2012Manufacturing and Production Exubera, Nantworks, Pfizer
A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …
Molecular Profiles starts work on clinical manufacturing facility
January 16, 2012Manufacturing and Production Molecular Profiles
UK contract research and manufacturing services company Molecular Profiles has announced a £9 million investment in manufacturing facilities in the …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
